VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.

VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.

Item
http://www.wikidata.org/entity/Q34581833
VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.Goyazensolide Induces Apoptosis in Cancer Cells in vitro and in vivo.Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells.Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells.N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
P2860

VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.

Item
http://www.wikidata.org/entity/Q34581833
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@ast
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@en
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@nl
type
label
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@ast
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@en
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@nl
prefLabel
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@ast
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@en
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
VMY-1-103, a dansylated analog ...... n LNCaP prostate cancer cells.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932